Latest Biotech News

Recent studies uncover novel molecular targets and therapeutic strategies for various cancers. From exploiting immune mechanisms to silence oncogenic pathways to pairing chemotherapy with...

Researchers are making significant strides in battery technology to meet growing energy demands sustainably. Advances include improved lithium–sulfur battery charge retention via new filtration...

Artificial intelligence and digital innovations are increasingly embedded in biotech and healthcare, enhancing research, diagnostics, and patient care. Platforms utilizing AI streamline clinical...

Danish biotech Genmab has agreed to acquire Netherlands-based Merus for approximately $8 billion. The acquisition centers on Merus’ lead asset petosemtamab, an EGFRxLGR5 bispecific antibody with...

Novartis received FDA approval for Rhapsido (remibrutinib), the first oral Bruton’s tyrosine kinase (BTK) inhibitor indicated as a second-line treatment for chronic spontaneous urticaria (CSU)....

Japanese pharmaceutical giant Takeda announced it will discontinue all cell therapy research and development activities, including platform technologies and clinic-ready programs without active...

Biopharma companies are intensifying adoption of digital transformation and AI to enhance manufacturing efficiency and drug discovery. Experts caution the need for critical education to prevent AI...

The FDA issued a complete response letter rejecting the NDA for CUTX-101, a copper replacement therapy for rare pediatric Menkes disease, citing manufacturing facility deficiencies. This setback...

Recent advancements in spatial proteomics include development of unbiased protein isolation via the Microscoop platform and the Deep Visual Proteomics (DVP) method enabling single-cell spatial...

Groundbreaking studies continue to elucidate the molecular basis of neurological diseases. Research identifies autoimmune T cell responses targeting C9orf72 protein in ALS, repositioning the...

Cancer therapeutics are advancing with novel immunotherapy and targeted agents. Ohio State researchers identify mechanisms of T cell exhaustion contributing to cancer immunotherapy failure....

Significant strides are underway in diagnostic and imaging modalities. AI-powered models predict prostate cancer Gleason scores using MRI and enhance extranodal extension detection in HPV-positive...

Genmab has agreed to acquire clinical-stage biotechnology company Merus for approximately $8 billion in an all-cash transaction aimed at expanding its late-stage oncology pipeline. The acquisition...

Pfizer has inked a groundbreaking pricing agreement with the White House to offer certain drugs at most-favored-nation pricing, aligning U.S. medication costs with lower prices in other developed...

Forge Genetics, a UK-based gene editing startup spun out from the University of Nottingham, has raised £2 million (approximately $2.7 million) in seed funding led by Mercia Ventures and supported...

Researchers from New York, including Susan Sharfstein, PhD, have partnered with DeepSeq.AI to develop an artificial intelligence model predicting the manufacturability of protein-based drugs in...

New studies by researchers at La Jolla Institute for Immunology and Columbia University Irving Medical Center reveal that amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder,...

A study published in BMC Cancer demonstrates that radiomic analysis of contrast-enhanced computed tomography (CECT) images combined with machine learning algorithms can predict perineural invasion...

Symbiosis Pharmaceutical Services has completed qualification of its new automated FPD 50 Flexicon fill/finish line at a commercial production facility in Stirling, Scotland. The line features a...

Carnegie Mellon University leads a multi-institutional collaboration awarded $26.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop next-generation at-home cancer...